-
2
-
-
0033846654
-
Hyaluronan is not just a goo!
-
Toole BP. Hyaluronan is not just a goo! J Clin Invest. 2000;106:335-336.
-
(2000)
J Clin Invest
, vol.106
, pp. 335-336
-
-
Toole, B.P.1
-
3
-
-
0036731866
-
Hyaluronan and tumor growth
-
Toole BP, Hascall VC. Hyaluronan and tumor growth. Am J Pathol. 2002;161:745-747.
-
(2002)
Am J Pathol
, vol.161
, pp. 745-747
-
-
Toole, B.P.1
Hascall, V.C.2
-
5
-
-
0036339293
-
CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma
-
Carinci F, Stabellini G, Calvitti M, et al. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg. 2002;13:85-89.
-
(2002)
J Craniofac Surg
, vol.13
, pp. 85-89
-
-
Carinci, F.1
Stabellini, G.2
Calvitti, M.3
-
6
-
-
0035404863
-
CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression
-
Bourguignon LY. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001;6:287-297.
-
(2001)
J Mammary Gland Biol Neoplasia
, vol.6
, pp. 287-297
-
-
Bourguignon, L.Y.1
-
7
-
-
0035319329
-
A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression
-
Franzmann E, Weed DT, Civantos F, Goodwin J, Bourguignon LY. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngol Head Neck Surg. 2001;124:426-432.
-
(2001)
Otolaryngol Head Neck Surg
, vol.124
, pp. 426-432
-
-
Franzmann, E.1
Weed, D.T.2
Civantos, F.3
Goodwin, J.4
Bourguignon, L.Y.5
-
8
-
-
0035966019
-
Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185HER2 and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth
-
Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185HER2 and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem. 2001;276:48679-48692.
-
(2001)
J Biol Chem
, vol.276
, pp. 48679-48692
-
-
Bourguignon, L.Y.1
Zhu, H.2
Zhou, B.3
Diedrich, F.4
Singleton, P.A.5
Hung, M.C.6
-
9
-
-
0036176638
-
CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells
-
Wobus M, Rangwala R, Sheyn I, et al. CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. App Immunohistochem Mol Morphology. 2002;10:34-39.
-
(2002)
App Immunohistochem Mol Morphology
, vol.10
, pp. 34-39
-
-
Wobus, M.1
Rangwala, R.2
Sheyn, I.3
-
10
-
-
0141592701
-
Epidermal growth factor receptor-stimulated activation of phospholipase C-gamma-1 promotes invasion of head and neck squamous cell carcinoma
-
Thomas SM, Coppelli FM, Wells A, et al. Epidermal growth factor receptor-stimulated activation of phospholipase C-gamma-1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res. 2003;63:5629-5635.
-
(2003)
Cancer Res
, vol.63
, pp. 5629-5635
-
-
Thomas, S.M.1
Coppelli, F.M.2
Wells, A.3
-
11
-
-
0043163868
-
EGFR family signaling and its association with breast cancer development and resistance to chemotherapy
-
Navolanic PM, Steelman LS, McCubrey JA. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol. 2003;22:237-252.
-
(2003)
Int J Oncol
, vol.22
, pp. 237-252
-
-
Navolanic, P.M.1
Steelman, L.S.2
McCubrey, J.A.3
-
12
-
-
0036342722
-
EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines
-
Tsatas D, Kanagasundaram V, Kaye A, Novak U. EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J Clin Neurosci. 2002;9:282-288.
-
(2002)
J Clin Neurosci
, vol.9
, pp. 282-288
-
-
Tsatas, D.1
Kanagasundaram, V.2
Kaye, A.3
Novak, U.4
-
13
-
-
0037215106
-
Targeting epidermal growth factor receptor in head and neck cancer
-
Ford AC, Grandis JR. Targeting epidermal growth factor receptor in head and neck cancer. Head Neck. 2003;25:67-73.
-
(2003)
Head Neck
, vol.25
, pp. 67-73
-
-
Ford, A.C.1
Grandis, J.R.2
-
14
-
-
0036462583
-
EGF receptor targeting in therapy-resistant human tumors
-
Schmidt M, Lichtner RB. EGF receptor targeting in therapy-resistant human tumors. Drug Resist Updat. 2002;5:11-18.
-
(2002)
Drug Resist Updat
, vol.5
, pp. 11-18
-
-
Schmidt, M.1
Lichtner, R.B.2
-
15
-
-
25844481618
-
Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
-
Bianco R, Troiani T, Tortora G, Fortunato C. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy. Endocr Relat Cancer. 2005;12:S159-S171.
-
(2005)
Endocr Relat Cancer
, vol.12
-
-
Bianco, R.1
Troiani, T.2
Tortora, G.3
Fortunato, C.4
-
17
-
-
0037063999
-
Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway
-
Ghatak S, Misra S, Toole B. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem. 2002;277:38013-38020.
-
(2002)
J Biol Chem
, vol.277
, pp. 38013-38020
-
-
Ghatak, S.1
Misra, S.2
Toole, B.3
-
18
-
-
0037478612
-
Regulation of multi-drug resistance in cancer cells by hyaluronan
-
Misra S, Ghatak S, Zoltan-Jones A, Toole B. Regulation of multi-drug resistance in cancer cells by hyaluronan. J Biol Chem. 2003;278:25285-25288.
-
(2003)
J Biol Chem
, vol.278
, pp. 25285-25288
-
-
Misra, S.1
Ghatak, S.2
Zoltan-Jones, A.3
Toole, B.4
-
19
-
-
0035393501
-
CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells
-
Bates RC, Edwards NS, Burns GF, Fisher DEA. CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res. 2001;61:5275-5283.
-
(2001)
Cancer Res
, vol.61
, pp. 5275-5283
-
-
Bates, R.C.1
Edwards, N.S.2
Burns, G.F.3
Dea, F.4
-
20
-
-
0034763605
-
CD44 mediates constitutive type 1 receptor signaling in cervical carcinoma cells
-
Wobus M, Kuns R, Wolf C, et al. CD44 mediates constitutive type 1 receptor signaling in cervical carcinoma cells. Gynecol Oncol. 2001;83:227-234.
-
(2001)
Gynecol Oncol
, vol.83
, pp. 227-234
-
-
Wobus, M.1
Kuns, R.2
Wolf, C.3
-
21
-
-
0033673670
-
Epidermal growth factor upregulates CD44-dependent astrocytoma invasion in vitro
-
Monaghan M, Mulligan KA, Gillespie H, et al. Epidermal growth factor upregulates CD44-dependent astrocytoma invasion in vitro. J Pathol. 2000;192:519-525.
-
(2000)
J Pathol
, vol.192
, pp. 519-525
-
-
Monaghan, M.1
Mulligan, K.A.2
Gillespie, H.3
-
22
-
-
15744404625
-
Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression
-
Bourguignon LY, Gilad E, Rothman K, Peyrollier K. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. J Biol Chem. 2005;280:11961-11972.
-
(2005)
J Biol Chem
, vol.280
, pp. 11961-11972
-
-
Bourguignon, L.Y.1
Gilad, E.2
Rothman, K.3
Peyrollier, K.4
-
23
-
-
0041342137
-
P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines
-
Bradford CR, Zhu S, Ogawa H, et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck. 2003;25:654-661.
-
(2003)
Head Neck
, vol.25
, pp. 654-661
-
-
Bradford, C.R.1
Zhu, S.2
Ogawa, H.3
-
24
-
-
0346365372
-
Glutathione S-transferase amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors
-
Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR. Glutathione S-transferase amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res. 2003;63:8097-8102.
-
(2003)
Cancer Res
, vol.63
, pp. 8097-8102
-
-
Cullen, K.J.1
Newkirk, K.A.2
Schumaker, L.M.3
Aldosari, N.4
Rone, J.D.5
Haddad, B.R.6
-
25
-
-
0033844889
-
Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer
-
Shiga H, Rasmussen AA, Johnston PG, et al. Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer. Head Neck. 2000;22(6):599-608.
-
(2000)
Head Neck
, vol.22
, Issue.6
, pp. 599-608
-
-
Shiga, H.1
Rasmussen, A.A.2
Johnston, P.G.3
-
26
-
-
0036732010
-
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance
-
Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res. 2002;62:5035-5040.
-
(2002)
Cancer Res
, vol.62
, pp. 5035-5040
-
-
Volk, E.L.1
Farley, K.M.2
Wu, Y.3
Li, F.4
Robey, R.W.5
Schneider, E.6
|